February 01, 2015 9:20 PM ET


Company Overview of Proacta, Inc.

Company Overview

Proacta, Inc., a biopharmaceutical company, engages in the development and commercialization of hypoxia-activated oncology drugs. It offers PR104, a hypoxia-selective small-molecule prodrug that is designed to improve the outcome of cancer patients by targeting cancer cells resistant to current treatments. Proacta, Inc. was incorporated in 2004 and is based in San Diego, California.

4275 Executive Square

Suite 440

La Jolla

San Diego, CA 92037

United States

Founded in 2004





Key Executives for Proacta, Inc.

Chief Executive Officer and Director
Age: 57
Age: 60
Chief Financial Officer
Chief Financial Officer of Proacta Therapeutics Limited
Executive Director of Clinical Development
Compensation as of Fiscal Year 2014.

Similar Private Companies By Industry

Company Name Region
Mirror Pharmaceuticals LLC United States
BPI Sports Holdings, LLC United States
Merial Inc. United States
INO Therapeutics LLC United States
SL Pharmaceuticals United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Bertelsmann AG Europe
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Rush University United States
Citizens Budget Commission United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Proacta, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.